Physician profile
Jasmine Singh
NPI 1235642919
$1,614.17
in general payments reported to CMS, 2019-2025
16 companies · $405 in 2025
The $405 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $29.01 · 2022: $265 · 2023: $330 · 2024: $585 · 2025: $405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,319.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $394.68 | 2021-2025 | |
| Edwards Lifesciences Corporation | $206.23 | 2022-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $172.29 | 2023-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $161.24 | 2023-2025 | Verquvo, Capvaxive |
| Amgen INC. | $141.11 | 2023-2024 | Repatha |
| Atricure, INC. | $122.95 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.79 | 2023-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $90.71 | 2023-2024 | Brilinta, Wainua |
| E.R. Squibb & Sons, L.L.C. | $54.20 | 2023-2024 | Camzyos, Eliquis |
| Pfizer INC. | $39.92 | 2022-2024 | |
| Baxter Healthcare | $30.50 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor |
| Janssen Pharmaceuticals, INC | $24.16 | 2024 | Xarelto |
| Boston Scientific Corporation | $21.77 | 2024 | Watchman Flx |
| Alnylam Pharmaceuticals INC. | $18.08 | 2025 | Amvuttra |
| Glaxosmithkline, LLC. | $17.13 | 2025 | Shingrix |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bridgebio Pharma, INC. | $15.41 | 2025 | Attruby |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jasmine Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.